PRESS RELEASE published on 03/03/2026 at 19:35, 4 months 29 days ago Inside Information / Other news releases ABIONYX Pharma releases monthly statement of total voting rights and shares on Euronext Paris. Company focuses on innovative medicines with lipid science expertise Euronext Paris Shares Total Voting Rights ABIONYX Pharma Innovative Medicines
BRIEF published on 02/04/2026 at 19:58, 5 months 25 days ago Voting rights and shares of ABIONYX on Euronext Paris Euronext Paris Share Capital Voting Rights AMF ABIONYX
BRIEF published on 02/04/2026 at 19:58, 5 months 25 days ago ABIONYX Reports Monthly Voting Rights and Shares Update Euronext Paris Share Capital Voting Rights AMF Regulations ABIONYX Pharma
PRESS RELEASE published on 02/04/2026 at 19:53, 5 months 25 days ago Inside Information / Other news releases ABIONYX Pharma releases monthly statement on total voting rights and shares. Company focuses on innovative medicines in rare diseases with lipid science expertise Shares Total Voting Rights Monthly Statement ABIONYX Pharma Innovative Medicines
BRIEF published on 01/28/2026 at 18:53, 6 months 4 days ago ABIONYX: Publication of the Number of Voting Rights and Shares Euronext Paris Share Capital Voting Rights Financial Transparency ABIONYX
BRIEF published on 01/23/2026 at 19:05, 6 months 9 days ago ABIONYX Pharma Announces 2026 Financial Calendar Financial Calendar Biopharma ABIONYX Pharma 2026 Updates Sepsis Care
BRIEF published on 01/23/2026 at 19:05, 6 months 9 days ago ABIONYX Pharma unveils its 2026 financial calendar Critical Care Innovative Therapies ABIONYX Pharma Sepsis Financial Calendar 2026
PRESS RELEASE published on 01/23/2026 at 19:00, 6 months 9 days ago Inside Information / Other news releases ABIONYX Pharma announces its financial calendar for 2026, including key events and dates for cash position updates and results releases Financial Calendar ABIONYX Pharma Sepsis 2026 Therapeutic Era
BRIEF published on 01/07/2026 at 19:17, 6 months 25 days ago ABIONYX Pharma's Half-Yearly Review of Liquidity Contract Liquidity Contract TP ICAP Europe Stock Market Transactions ABIONYX Pharma Stocks And Cash
PRESS RELEASE published on 01/07/2026 at 19:12, 6 months 25 days ago Inside Information / Other news releases ABIONYX Pharma releases half-yearly report on liquidity contract with TP ICAP (Europe) SA, detailing shares and cash balance for 2025 Liquidity Contract Shares TP ICAP Cash Balance ABIONYX Pharma
Published on 08/01/2026 at 01:20, 1 day 11 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 1 day 11 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 1 day 12 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 1 day 13 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/02/2026 at 08:15, 4 hours 21 minutes ago Holcim signs agreement to divest its business in the Philippines
Published on 08/01/2026 at 16:35, 20 hours ago HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 1 day 16 hours ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 1 day 17 hours ago Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 21:00, 1 day 15 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:13, 1 day 17 hours ago Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 1 day 18 hours ago Covivio Hotels - 2026 Half-year financial report
